Health technology assessment (HTA) is a multidisciplinary process that summarizes information about the medical, social, economic, and ethical issues related to the use of medical technologies in a systematic, transparent, unbiased, and robust manner.
The key objective of HTA is to advise policymakers and providers about the necessity of adopting and appropriateness of reimbursing procedures, devices, and In-Vitro Diagnostics (IVD) tests.
Most developed countries have functioning HTA frameworks on different levels (national, regional, and hospital-based). In Europe alone, three hundred and thirty-seven med tech HTA reports were released in 2018, with two hundred and fifty-six reports in 2019.
HTA plays an important role in the market access landscape for medical technologies. Very often, HTA is a formal part of the reimbursement or funding processes (e.g., in France or Norway). Even if not formally connected to the reimbursement process, HTA still significantly impacts the adoption of technologies (e.g., in England).
Market access professionals closely monitor initiated and published HTAs for the products under their supervision. The key challenges for effective monitoring are the large number of HTA organizations, language barriers, and lack of time to properly perform the necessary monitoring.
MTRC offers a unique service of monitoring developments with initiated or published HTA reports for medical technologies globally, so that our clients do not miss a single HTA for their technology.
Key features of the HTA Alerts service
More than 500 HTA reports (published, initiated, ongoing) globally are detected every two weeks (about 300 hundred reports in Europe alone).
Trusted by 40% of the top 30 global med tech companies
Get in touch
Contact us to discuss your needs and learn about our services